EP Patent

EP4076426A1 — Compositions of bile acids and phenylbutyrate compounds

Assigned to Amylyx Pharmaceuticals Inc · Expires 2022-10-26 · 4y expired

What this patent protects

The present disclosure relates to compositions including a phenylbutyrate compound and a bile acid, and methods of processing such compositions.

USPTO Abstract

The present disclosure relates to compositions including a phenylbutyrate compound and a bile acid, and methods of processing such compositions.

Drugs covered by this patent

sodium-phenylbutyrate (SODIUM PHENYLBUTYRATE)

Patent Metadata

Patent number: EP4076426A1
Jurisdiction: EP
Classification: —
Expires: 2022-10-26
Drug substance claim: No
Drug product claim: No
Assignee: Amylyx Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.